PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Postgraduate Medical School, University of Chieti, 66013 Chieti, Italy.\', \'School of Pharmacy, University of Camerino, 62032 Camerino, Italy.\', \'Department of Biomedical Sciences and Specialist Surgery, Section of Ophthalmology, University of Ferrara, 44121 Ferrara, Italy.\', \'University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104, USA.\', \'Department of Microbiology, University of Thessaloniki, 54124 Thessaloniki, Greece.\', \'School of Veterinary Medicine, University of Thessaloniki, 54124 Thessaloniki, Greece.\', \'Centro Medico \'Mai più Dolore\', 65100 Pescara, Italy.\', \'Maxillofacial Surgery \'G. Mazzini\' Hospital, 64100 Teramo, Italy.\', \'Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00100 Roma, Italy.\', \'Department of Medical, Oral and Biotechnological Sciences, University of Chieti, Chieti, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.23812/20-34-4EDIT-65
?:hasPublicationType
?:journal
  • Journal of biological regulators and homeostatic agents
is ?:pmid of
?:pmid
?:pmid
  • 32744052
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.407
?:rankingScore_hIndex
  • 37
is ?:relation_isRelatedTo_publication of
?:title
  • IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
?:type

Metadata

Anon_0  
expand all